Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2023-06, Vol.41 (S2), p.430-432 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 432 |
|---|---|
| container_issue | S2 |
| container_start_page | 430 |
| container_title | Hematological oncology |
| container_volume | 41 |
| creator | Bock, A. M. Mwangi, R. Wang, Y. Khurana, A. Maurer, M. J. Ayers, A. Kahl, B. Martin, P. Cohen, J. Casulo, C. Lossos, I. Farooq, U. Ayyappan, S. Reicks, T. Habermann, T. M. Flowers, C. R. Cerhan, J. R. Nastoupil, L. J. Nowakowski, G. S. |
| description | |
| doi_str_mv | 10.1002/hon.3164_317 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3089986855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3089986855</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1924-6b4d2e5e482c1f03fe01c823f8f97e14d65ae3501cb3ed0ae68fcebdc3ca7d7f3</originalsourceid><addsrcrecordid>eNp9kMlOwzAURS0EEqWw4wMssQGJFA8ZnCVtgSJFFDFssVznuU2VxMVuirrjE_hGvoRUgS2r-4ajd_UuQqeUDCgh7Gph6wGncSg5TfZQj5I0DSiJ033UIywRAWGcHaIj75eEtDsieuhtDKaoi3qOH11RKbfFT2Cc0mvbluPCmMYDzpSbAx5-f35pKEucbavVwlYKn4-z4Si7wEPlIce2xs-N2xQbVeJps9a2An-MDowqPZz8ah-93t68jCZBNr27H11ngaYpC4N4FuYMIggF09QQboBQLRg3wqQJ0DCPIwU8aoczDjlREAujYZZrrlWSJ4b30Vl3d-XsewN-LZe2cXVrKTkRaSpiEUUtddlR2lnvHRi56p6WlMhdgrJNUP4l2OJRh38UJWz_ZeVk-rCTXc9_ANJMdWU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089986855</pqid></control><display><type>article</type><title>Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bock, A. M. ; Mwangi, R. ; Wang, Y. ; Khurana, A. ; Maurer, M. J. ; Ayers, A. ; Kahl, B. ; Martin, P. ; Cohen, J. ; Casulo, C. ; Lossos, I. ; Farooq, U. ; Ayyappan, S. ; Reicks, T. ; Habermann, T. M. ; Flowers, C. R. ; Cerhan, J. R. ; Nastoupil, L. J. ; Nowakowski, G. S.</creator><creatorcontrib>Bock, A. M. ; Mwangi, R. ; Wang, Y. ; Khurana, A. ; Maurer, M. J. ; Ayers, A. ; Kahl, B. ; Martin, P. ; Cohen, J. ; Casulo, C. ; Lossos, I. ; Farooq, U. ; Ayyappan, S. ; Reicks, T. ; Habermann, T. M. ; Flowers, C. R. ; Cerhan, J. R. ; Nastoupil, L. J. ; Nowakowski, G. S.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.3164_317</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma</subject><ispartof>Hematological oncology, 2023-06, Vol.41 (S2), p.430-432</ispartof><rights>2023 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1924-6b4d2e5e482c1f03fe01c823f8f97e14d65ae3501cb3ed0ae68fcebdc3ca7d7f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.3164_317$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.3164_317$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Bock, A. M.</creatorcontrib><creatorcontrib>Mwangi, R.</creatorcontrib><creatorcontrib>Wang, Y.</creatorcontrib><creatorcontrib>Khurana, A.</creatorcontrib><creatorcontrib>Maurer, M. J.</creatorcontrib><creatorcontrib>Ayers, A.</creatorcontrib><creatorcontrib>Kahl, B.</creatorcontrib><creatorcontrib>Martin, P.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Casulo, C.</creatorcontrib><creatorcontrib>Lossos, I.</creatorcontrib><creatorcontrib>Farooq, U.</creatorcontrib><creatorcontrib>Ayyappan, S.</creatorcontrib><creatorcontrib>Reicks, T.</creatorcontrib><creatorcontrib>Habermann, T. M.</creatorcontrib><creatorcontrib>Flowers, C. R.</creatorcontrib><creatorcontrib>Cerhan, J. R.</creatorcontrib><creatorcontrib>Nastoupil, L. J.</creatorcontrib><creatorcontrib>Nowakowski, G. S.</creatorcontrib><title>Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes</title><title>Hematological oncology</title><subject>Lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAURS0EEqWw4wMssQGJFA8ZnCVtgSJFFDFssVznuU2VxMVuirrjE_hGvoRUgS2r-4ajd_UuQqeUDCgh7Gph6wGncSg5TfZQj5I0DSiJ033UIywRAWGcHaIj75eEtDsieuhtDKaoi3qOH11RKbfFT2Cc0mvbluPCmMYDzpSbAx5-f35pKEucbavVwlYKn4-z4Si7wEPlIce2xs-N2xQbVeJps9a2An-MDowqPZz8ah-93t68jCZBNr27H11ngaYpC4N4FuYMIggF09QQboBQLRg3wqQJ0DCPIwU8aoczDjlREAujYZZrrlWSJ4b30Vl3d-XsewN-LZe2cXVrKTkRaSpiEUUtddlR2lnvHRi56p6WlMhdgrJNUP4l2OJRh38UJWz_ZeVk-rCTXc9_ANJMdWU</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Bock, A. M.</creator><creator>Mwangi, R.</creator><creator>Wang, Y.</creator><creator>Khurana, A.</creator><creator>Maurer, M. J.</creator><creator>Ayers, A.</creator><creator>Kahl, B.</creator><creator>Martin, P.</creator><creator>Cohen, J.</creator><creator>Casulo, C.</creator><creator>Lossos, I.</creator><creator>Farooq, U.</creator><creator>Ayyappan, S.</creator><creator>Reicks, T.</creator><creator>Habermann, T. M.</creator><creator>Flowers, C. R.</creator><creator>Cerhan, J. R.</creator><creator>Nastoupil, L. J.</creator><creator>Nowakowski, G. S.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202306</creationdate><title>Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes</title><author>Bock, A. M. ; Mwangi, R. ; Wang, Y. ; Khurana, A. ; Maurer, M. J. ; Ayers, A. ; Kahl, B. ; Martin, P. ; Cohen, J. ; Casulo, C. ; Lossos, I. ; Farooq, U. ; Ayyappan, S. ; Reicks, T. ; Habermann, T. M. ; Flowers, C. R. ; Cerhan, J. R. ; Nastoupil, L. J. ; Nowakowski, G. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1924-6b4d2e5e482c1f03fe01c823f8f97e14d65ae3501cb3ed0ae68fcebdc3ca7d7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bock, A. M.</creatorcontrib><creatorcontrib>Mwangi, R.</creatorcontrib><creatorcontrib>Wang, Y.</creatorcontrib><creatorcontrib>Khurana, A.</creatorcontrib><creatorcontrib>Maurer, M. J.</creatorcontrib><creatorcontrib>Ayers, A.</creatorcontrib><creatorcontrib>Kahl, B.</creatorcontrib><creatorcontrib>Martin, P.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Casulo, C.</creatorcontrib><creatorcontrib>Lossos, I.</creatorcontrib><creatorcontrib>Farooq, U.</creatorcontrib><creatorcontrib>Ayyappan, S.</creatorcontrib><creatorcontrib>Reicks, T.</creatorcontrib><creatorcontrib>Habermann, T. M.</creatorcontrib><creatorcontrib>Flowers, C. R.</creatorcontrib><creatorcontrib>Cerhan, J. R.</creatorcontrib><creatorcontrib>Nastoupil, L. J.</creatorcontrib><creatorcontrib>Nowakowski, G. S.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bock, A. M.</au><au>Mwangi, R.</au><au>Wang, Y.</au><au>Khurana, A.</au><au>Maurer, M. J.</au><au>Ayers, A.</au><au>Kahl, B.</au><au>Martin, P.</au><au>Cohen, J.</au><au>Casulo, C.</au><au>Lossos, I.</au><au>Farooq, U.</au><au>Ayyappan, S.</au><au>Reicks, T.</au><au>Habermann, T. M.</au><au>Flowers, C. R.</au><au>Cerhan, J. R.</au><au>Nastoupil, L. J.</au><au>Nowakowski, G. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes</atitle><jtitle>Hematological oncology</jtitle><date>2023-06</date><risdate>2023</risdate><volume>41</volume><issue>S2</issue><spage>430</spage><epage>432</epage><pages>430-432</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.3164_317</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2023-06, Vol.41 (S2), p.430-432 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_3089986855 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Lymphoma |
| title | Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A50%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20Primary%20Refractory%20Diffuse%20Large%20B%E2%80%90cell%20Lymphoma%20(DLBCL)%20Based%20on%20Survival%20Outcomes&rft.jtitle=Hematological%20oncology&rft.au=Bock,%20A.%20M.&rft.date=2023-06&rft.volume=41&rft.issue=S2&rft.spage=430&rft.epage=432&rft.pages=430-432&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.3164_317&rft_dat=%3Cproquest_cross%3E3089986855%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089986855&rft_id=info:pmid/&rfr_iscdi=true |